{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:22:33Z","timestamp":1771870953349,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,23]]},"DOI":"10.7759\/cureus.104131","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:55:59Z","timestamp":1771869359000},"source":"Crossref","is-referenced-by-count":0,"title":["Locally Advanced Basal Cell Carcinoma With Orbital Invasion: Treatment With Neoadjuvant Hedgehog Pathway Inhibition and Palliative Enucleation"],"prefix":"10.7759","author":[{"given":"Matthew A","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Basal cell carcinoma: epidemiology","volume":"4","author":"Gangan R","year":"2022","unstructured":"Gangan R. Basal cell carcinoma: epidemiology. J Skin Sex Transmitted Dis. 2022, 4:157-163.","journal-title":"J Skin Sex Transmitted Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S130371","article-title":"Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment","volume":"10","author":"Shi Y","year":"2017","unstructured":"Shi Y, Jia R, Fan X. Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment. Onco Targets Ther. 2017, 10:2483-9. 10.2147\/OTT.S130371","journal-title":"Onco Targets Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S325852","article-title":"Current perspectives in the treatment of locally advanced basal cell carcinoma","volume":"16","author":"Gupta N","year":"2022","unstructured":"Gupta N, Ruiz ES. Current perspectives in the treatment of locally advanced basal cell carcinoma. Drug Des Devel Ther. 2022, 16:183-90. 10.2147\/DDDT.S325852","journal-title":"Drug Des Devel Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2024.11.012","article-title":"Updates in management of locally and regionally advanced basal cell carcinoma","volume":"105","author":"Lourdault K","year":"2025","unstructured":"Lourdault K, Crosby B, McCabe J, Essner R. Updates in management of locally and regionally advanced basal cell carcinoma. Surg Clin North Am. 2025, 105:629-38. 10.1016\/j.suc.2024.11.012","journal-title":"Surg Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.8827","article-title":"Efficacy and safety of Hedgehog inhibitors for advanced basal cell carcinoma: an expert consensus panel","volume":"24","author":"Burshtein J","year":"2025","unstructured":"Burshtein J, Shah M, Zakria D, et al.. Efficacy and safety of Hedgehog inhibitors for advanced basal cell carcinoma: an expert consensus panel. J Drugs Dermatol. 2025, 24:465-71. 10.36849\/JDD.8827","journal-title":"J Drugs Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000537817","article-title":"Management of locally advanced basal cell carcinoma with sonic hedgehog pathway targeted therapy: a case report and discussion","volume":"16","author":"Ferrin N","year":"2024","unstructured":"Ferrin N, Edmond D, Jones R, McCahill LE. Management of locally advanced basal cell carcinoma with sonic hedgehog pathway targeted therapy: a case report and discussion. Case Rep Dermatol. 2024, 16:75-82. 10.1159\/000537817","journal-title":"Case Rep Dermatol"},{"key":"ref7","article-title":"Advanced periocular basal cell carcinoma with orbital invasion: a case report","volume":"26","author":"Shree J","year":"2025","unstructured":"Shree J, Mehrotra N, Singh S. Advanced periocular basal cell carcinoma with orbital invasion: a case report. UP Journal of Ophthalmology. 2025, 26:76-9.","journal-title":"UP Journal of Ophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13160","article-title":"Basal cell carcinoma: a comprehensive review for the radiologist","volume":"204","author":"Baheti AD","year":"2015","unstructured":"Baheti AD, Tirumani SH, Giardino A, Rosenthal MH, Tirumani H, Krajewski K, Ramaiya NH. Basal cell carcinoma: a comprehensive review for the radiologist. AJR Am J Roentgenol. 2015, 204:W132-40. 10.2214\/AJR.14.13160","journal-title":"AJR Am J Roentgenol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01493-2","article-title":"Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial","volume":"36","author":"Gershoni A","year":"2022","unstructured":"Gershoni A, Tiosano A, Ishai MB, Barayev E, Ben Simon GJ, Yassur I. Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial. Eye (Lond). 2022, 36:407-13. 10.1038\/s41433-021-01493-2","journal-title":"Eye (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic A","year":"2012","unstructured":"Sekulic A, Migden MR, Oro AE, et al.. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012, 366:2171-9. 10.1056\/NEJMoa1113713","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.08.022","article-title":"Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial","volume":"86","author":"Basset-S\u00e9guin N","year":"2017","unstructured":"Basset-S\u00e9guin N, Hauschild A, Kunstfeld R, et al.. Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial. Eur J Cancer. 2017, 86:334-48. 10.1016\/j.ejca.2017.08.022","journal-title":"Eur J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.06.007","article-title":"Oral hedgehog inhibitor, vismodegib, for locally advanced periorbital and orbital basal cell carcinoma. A report by the American Academy of Ophthalmology","volume":"131","author":"Wladis EJ","year":"2024","unstructured":"Wladis EJ, Aakalu VK, Vagefi MR, et al.. Oral hedgehog inhibitor, vismodegib, for locally advanced periorbital and orbital basal cell carcinoma. A report by the American Academy of Ophthalmology. Ophthalmology. 2024, 131:1339-44. 10.1016\/j.ophtha.2024.06.007","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/10966218251409052","article-title":"Painful eye caused by neoplasm: a case report and review","author":"Ouellette M","year":"2025","unstructured":"Ouellette M, Agi J, Murphy M. Painful eye caused by neoplasm: a case report and review. J Palliat Med. 2025, 10.1177\/10966218251409052","journal-title":"J Palliat Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297531","article-title":"Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: a real-world single-center retrospective review","volume":"19","author":"Patel S","year":"2024","unstructured":"Patel S, Armbruster H, Pardo G, et al.. Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: a real-world single-center retrospective review. PLoS One. 2024, 19:e0297531. 10.1371\/journal.pone.0297531","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465107-locally-advanced-basal-cell-carcinoma-with-orbital-invasion-treatment-with-neoadjuvant-hedgehog-pathway-inhibition-and-palliative-enucleation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:56:00Z","timestamp":1771869360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465107-locally-advanced-basal-cell-carcinoma-with-orbital-invasion-treatment-with-neoadjuvant-hedgehog-pathway-inhibition-and-palliative-enucleation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.104131","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,23]]}}}